Screening for primary hyperaldosteronism
What are the indications for screening for primary hyperaldosteronism?
What are the indications for screening for primary hyperaldosteronism?
What are the diagnostic criteria for subclinical hypothyroidism in pregnant women? Do they differ from the criteria used in the general population?
It is now recommended to use population-based trimester-specific thyroid-stimulating hormone (TSH) reference ranges, but what should be the optimal TSH level for a woman before pregnancy?
Should separate thyroid-stimulating hormone (TSH) reference ranges be determined for different age groups in the general population?
How to treat patients with hypertension and metabolic syndrome? Do you agree with the opinion that beta-blockers and diuretics are contraindicated in such patients?
Are any classes of antihypertensive drugs preferred in patients with diabetes?
Is the thyroid-stimulating hormone (TSH) level a stable parameter? Do laboratory errors occur? Is every measurement reliable?
Should every pregnant woman with elevated anti-thyroid peroxidase antibodies be treated with levothyroxine?
Would you recommend discontinuation of regular computed tomography scans in a patient with a nonfunctioning incidentaloma and no tumor growth over 3- or 5-year follow-up?
How often and for how long should computed tomography be repeated in the follow-up of a nonfunctioning adrenal incidentaloma?